News coverage about VWR (NASDAQ:VWR) has been trending positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. VWR earned a media sentiment score of 0.29 on Accern’s scale. Accern also assigned headlines about the medical research company an impact score of 47.1322758750217 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Several analysts have recently weighed in on VWR shares. Zacks Investment Research upgraded VWR from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a report on Tuesday, September 12th. ValuEngine upgraded VWR from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. Finally, BidaskClub upgraded VWR from a “strong sell” rating to a “sell” rating in a report on Friday, August 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $31.67.
VWR (NASDAQ VWR) opened at $33.25 on Wednesday. The stock has a market capitalization of $4,380.00 and a P/E ratio of 17.32. VWR has a twelve month low of $24.42 and a twelve month high of $37.25. The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.09.
VWR (NASDAQ:VWR) last issued its earnings results on Tuesday, November 7th. The medical research company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.08. VWR had a return on equity of 15.90% and a net margin of 3.27%. The company had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.16 billion. During the same period in the prior year, the firm earned $0.44 earnings per share. VWR’s revenue for the quarter was up 5.2% on a year-over-year basis. sell-side analysts anticipate that VWR will post 1.85 earnings per share for the current fiscal year.
VWR Company Profile
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with MarketBeat.com's FREE daily email newsletter.